【Medikit】Completion of Share Buyback of Restricted Shares｜July 2026

Overview of Capital Policy

Medikit disposed of 12,700 shares of treasury stock as part of its restricted stock compensation program, raising approximately 35.39 million Yen in total. The disposal was conducted on July 24, 2026, at a price of 2,787 Yen per share. The recipients included directors and officers of subsidiaries, aiming to enhance shareholder value and strengthen executive incentives.

Future Outlook and Impact on Shareholders

The disposal of treasury stock was carried out as part of the company's capital efficiency initiatives and executive compensation framework. The funds raised are expected to be utilized for future business investments and growth strategies. The dilution effect on shares is limited, and the measure aims to maintain and improve shareholder value.